The Recall Desk
ModerateFDA (Drugs)·D-1043-2022·Announced 2022-06-15

FDA Recalls Prescription Lidocaine Patch Due to Temperature Exposure

McKesson Medical-Surgical is recalling Lidocaine Patch 5% nationwide due to temperature abuse during distribution that may have compromised product quality. The FDA classified this as a Class II recall.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard involves a manufacturing deviation (temperature exposure) during distribution, which is precautionary in nature and does not represent a direct threat to patient safety.

Plain-English summary

McKesson Medical-Surgical Inc. is recalling Lidocaine Patch 5% (Rx only) manufactured by Qualitest Products. The recall affects product distributed nationwide across the United States.

The FDA classified this as a Class II recall due to cGMP deviations involving temperature abuse during distribution. Temperature exposure may have affected the product's integrity and quality.

No illnesses or injuries have been reported in connection with this recall. Patients and healthcare providers should contact McKesson Medical-Surgical or their healthcare provider with questions about affected product.

The recalled product

Product
LIDOCAINE (LIDOCAINE)
Brand
LIDOCAINE
Category
Drug

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 130 products in this recall →